Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 1;35(11):1574-1588.
doi: 10.1681/ASN.0000000512. Epub 2024 Sep 18.

ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases

T Alp Ikizler  1 , Holly J Kramer  2 , Srinivasan Beddhu  3 , Alex R Chang  4 , Allon N Friedman  5 , Meera N Harhay  6 , Elizabeth Yakes Jimenez  7 , Brandon Kistler  8 , Aleksandra Kukla  9 , Kristin Larson  10 , LindaMarie U Lavenburg  11 , Sankar Dass Navaneethan  12 , John Ortiz  13 , Rocio I Pereira  14 , David B Sarwer  15 , Philip R Schauer  16 , Evan M Zeitler  17 ; ASN Kidney Health Guidance Workgroup on Obesity and Kidney Diseases
Affiliations

ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases

T Alp Ikizler et al. J Am Soc Nephrol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure forms, as provided by each author, are available with the online version of the article at http://links.lww.com/JSN/E859.

Figures

Figure 1
Figure 1
Unhealthy weight treatment algorithm. The unhealthy weight treatment algorithm depicts an ideal framework to support clinical decision making for the management of unhealthy weight in adults 18 years and older living with kidney diseases. CAD, coronary artery disease; GIP, glucose-dependent insulinotropic polypeptide; GLP-1 RA, glucagon-like peptide-1 receptor agonist.
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention. Obesity. U.S. Centers for Disease Control and Prevention; 2024. Accessed July 15, 2024. https://www.cdc.gov/obesity/index.html
    1. Nowak KL You Z Gitomer B, et al. Overweight and obesity are predictors of progression in early autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2018;29(2):571–578. doi: 10.1681/ASN.2017070819 - DOI - PMC - PubMed
    1. Xu T, Sheng Z, Yao L. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment. Front Med. 2017;11(3):340–348. doi: 10.1007/s11684-017-0570-3 - DOI - PubMed
    1. D'Agati VD Chagnac A de Vries AP, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016;12(8):453–471. doi: 10.1038/nrneph.2016.75 - DOI - PubMed
    1. Wu C, Wang AY, Li G, Wang L. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy. BMC Nephrol. 2018;19(1):381. doi: 10.1186/s12882-018-1164-2 - DOI - PMC - PubMed

LinkOut - more resources